Israel Englander’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-76,800
Closed -$4.22M 6428
2024
Q4
$4.22M Buy
+76,800
New +$3.89M ﹤0.01% 2970
2024
Q1
Sell
-7,100
Closed -$253K 6688
2023
Q4
$253K Buy
+7,100
New +$247K ﹤0.01% 5055
2023
Q3
Sell
-23,600
Closed -$887K 6601
2023
Q2
$887K Buy
+23,600
New +$776K ﹤0.01% 4135

Other funds holding VCEL

Israel Englander's VCEL Position: Q2 2026 in Review

Israel Englander sold out of Vericel Corp (VCEL) in Q2 2026, closing a stake of 13,849 shares — an estimated $446K sold.

Israel Englander first reported a position in VCEL in Q1 2014 and held it in 34 quarters. The position peaked at $9.83M in Q4 2022. 318 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Israel Englander reported no remaining Vericel Corp position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 13,849 Vericel Corp shares in Q2 2026, an estimated $446K.
  • Israel Englander first reported a position in Vericel Corp in Q1 2014 and held it in 34 quarters.
  • Israel Englander's Vericel Corp position peaked at $9.83M in Q4 2022.
  • 318 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.